Perceptive Advisors LLC Global Blood Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

$3.83 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $22.4 Million - $47.2 Million	-692,807 Reduced 22.98%	2,322,247 $158 Million
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $19.6 Million - $32.8 Million	-877,439 Reduced 22.54%	3,015,054 $96.3 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $11.4 Million - $15.8 Million	442,578 Added 12.83%	3,892,493 $135 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $23.8 Million - $38.5 Million	-957,484 Reduced 21.72%	3,449,915 $101 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $6.49 Million - $9.51 Million	254,710 Added 6.13%	4,407,399 $112 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $29.4 Million - $39.3 Million	-905,953 Reduced 17.91%	4,152,689 $145 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $24 Million - $31.3 Million	-616,069 Reduced 10.86%	5,058,642 $206 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $4.75 Million - $8.05 Million	-126,285 Reduced 2.18%	5,674,711 $246 Million
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $2.17 Million - $3.06 Million	-41,104 Reduced 0.7%	5,800,996 $320 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $10.9 Million - $18.3 Million	-223,626 Reduced 3.69%	5,842,100 $369 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $8.34 Million - $17.4 Million	200,000 Added 3.41%	6,065,726 $310 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $457,000 - $818,600	-10,000 Reduced 0.17%	5,865,726 $466 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $4.54 Million - $5.79 Million	100,000 Added 1.73%	5,875,726 $285 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $13.2 Million - $15.8 Million	250,000 Added 4.52%	5,775,726 $304 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $4 Million - $5.35 Million	100,000 Added 1.84%	5,525,726 $292 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $8.73 Million - $12.9 Million	276,816 Added 5.38%	5,425,726 $223 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $12.2 Million - $16.4 Million	320,000 Added 6.63%	5,148,910 $196 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $6.2 Million - $8.03 Million	-160,156 Reduced 3.21%	4,828,910 $218 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $3.96 Million - $6.59 Million	100,000 Added 2.05%	4,989,066 $241 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $18.6 Million - $28.6 Million	625,000 Added 14.66%	4,889,066 $192 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $107 Million - $132 Million	4,264,066	4,264,066 $132 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account